Recent developments of RNA-based vaccines in cancer immunotherapy.

Elnaz Faghfuri Farhad Pourfarzi Amir Hossein FaghfouriMahdi Abdoli ShadbadKhalil Haji-Asgarzadeh Behzad Baradaran

Published in: Expert opinion on biological therapy (2020)

RNA vaccines are now in early clinical development with promising safety and efficacy outcomes. Also, the translation capacity and durability of these vaccines can be increased with chemical modifications and sequence engineering.

Keyphrases

nucleic acid
metabolic syndrome
adipose tissue
skeletal muscle
insulin resistance